Stryker (SYK) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Stryker Corp  (NYSE: SYK)
 

Stryker Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SYK Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 9.42 % 7.83 % 9.19 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 9.45 % -1.87 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 8.48 % 7.24 % 7.99 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 2.24 % 1.79 % 2.09 % 2.61 %
Revenue 5 Year Average Growth 11.84 % 10.68 % 8.65 % 10.59 %


SYK's Growth Comparisons in II. Quarter 2026




Comparing 9.42% year on year Revenue growth in the second quarter 2026, Stryker outperformed the 7.83% growth in the Medical Equipment & Supplies industry, and 9.19% growth in the Healthcare sector.

Comparing the company's Revenue to the first quarter results, sales were higher by 9.45% . On the yearly basis, average annual sales growth for Stryker is 11.84%, while S & P 500's including only Businesses with the second quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

SYK Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Orthopaedic Instruments
1.03 %
-
Other Orthopedics
18.05 %
-
Neuro Cranial Instruments
7.64 %
-
Enabling Technologies
-10.34 %
-
United States
0.81 %
-
International
8.27 %
-
MedSurg and Neurotechnology
4.94 %
-
MedSurg and Neurotechnology United States
3.19 %
-
MedSurg and Neurotechnology International
11.58 %
-
MedSurg and Neurotechnology Instruments
9.79 %
-
MedSurg and Neurotechnology Instruments United States
9.12 %
-
MedSurg and Neurotechnology Instruments International
13.24 %
-
MedSurg and Neurotechnology Endoscopy
0.12 %
-
MedSurg and Neurotechnology Endoscopy United States
-1.27 %
-
MedSurg and Neurotechnology Endoscopy International
6.37 %
-
MedSurg and Neurotechnology Medical
-4.55 %
-
MedSurg and Neurotechnology Medical United States
-6.86 %
-
MedSurg and Neurotechnology Medical International
8.39 %
-
MedSurg and Neurotechnology Vascular
27.34 %
-
MedSurg and Neurotechnology Vascular United States
37.93 %
-
MedSurg and Neurotechnology Vascular International
16.75 %
-
Orthopaedics
0.11 %
-
Orthopaedics United States
-2.03 %
-
Orthopaedics International
5.59 %
-
Orthopaedics Knees
4.85 %
-
Orthopaedics Knees United States
1.72 %
-
Orthopaedics Knees International
13.14 %
-
Orthopaedics Hips
3.84 %
-
Orthopaedics Hips United States
2.6 %
-
Orthopaedics Hips International
5.75 %
-
Orthopaedics Trauma and Extremities
9.52 %
-
Orthopaedics Trauma and Extremities United States
7.57 %
-
Orthopaedics Trauma and Extremities International
15.52 %
-
Orthopaedics Ortho Tech
4.7 %
-
Orthopaedics Ortho Tech United States
1.74 %
-
Orthopaedics Ortho Tech International
13.29 %
-
Orthopaedics Spinal Implants
-98.8 %
-
Orthopaedics Spinal Implants International
-95.83 %
-
Total
2.63 %
-


Growth Rates of SYK's Income in the second quarter 2026


SYK Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 49.06 % 14.39 % 5.13 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) 77.24 % 96.14 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) 53.04 % 13.87 % 30.96 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) 10.95 % 3.58 % 4.91 % 20.86 %
Operating Income 5 Year Avg. Change 17.07 % 11.5 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 44.34 % -9.84 % -25.81 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) 71.28 % 19.69 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 27.79 % 80.6 % 9.85 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 11.75 % -1.63 % -4.69 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 15.21 % 5.35 % 0.17 % -28.52 %

SYK Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 44.34 % -12.27 % -26.29 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) 71.28 % 44.98 % -0.86 % 27.07 %
Y / Y Net Income Change (Q2 TTM) 27.79 % -0.3 % 15.48 % 57.33 %
Sequential Net Income Change (Q2 TTM) 11.75 % -3.29 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth 15.21 % 4.12 % 9.21 % 22.96 %

SYK's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 43.1 % -15.76 % -25.81 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 70.26 % 15.71 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 27.49 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 11.44 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 14.79 % -1.8 % 0.17 % -28.52 %



SYK EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 44.1 % -18.03 % -26.29 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) 70.98 % 40.16 % -0.86 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 11.69 % - -4.12 % 4.93 %
EPS Net 5 Year Avg. Change 14.87 % 4.12 % 9.21 % 22.96 %



Stryker showed impressive 44.1% year on year rise in the second quarter to $3.30, despite the -18.03% inMedical Equipment & Supplies industry, Healthcare sector dropped -26.29%. Slow second quarter 2026 income per share, in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in the Stryker Corp results which underperformed overall market.

The bottom-line grew by 70.98% from the first quarter. Average yearly income per share growth for Stryker is 14.87%, while S & P 500's average annual income per share increase is 22.96% over the five years, including only Businesses with the second quarter 2026 earnings reports.

SYK Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 14.12 % 63.73 % 48.48 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) 155.18 % -54.09 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 16.85 % 45.27 % 19.59 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 2.87 % 9.74 % 5.76 % 15.75 %
Free Cash Flow 5 Year Avg. Change 8.95 % 3.81 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) 0.4 % - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - -9.69 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 10.38 % 4.81 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 21.69 % -21.5 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) 10.92 % -1.55 % 7.77 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 2.36 % -1.66 % 1.52 % 23.05 %
Capital Expenditures 5 Year Avg. Change 9.34 % 8.3 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.